Endpoints News News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Death, Injuries After Turbulence; More Herds with H5N1; Water Cyberattack Warning

Health news and commentary gathered by <em>MedPage Today</em> staff

Kennesaw state universityUnited statesSaudi arabiaKingdom of saudi arabiaKatie britt alaAlasia franklinHims hers healthRural developmentToxicological sciencesSenate republicans ted cruz texasMichigan department of agricultureEnvironmental protection agencyDrug enforcement administrationResearch projects agency for healthSingapore airlinesMichigan department

No, Telehealth Isn t Dead—but It Has Some Adjusting to Do

Some virtual care businesses are going under. Physicians and telemedicine leaders weigh in on what needs to change.

United statesSean slovenskiSree chaguturuMargot robbieSpencer dornMelissa bairdWalmart health virtual careTeladoc healthDepartment of medicineUniversity of north carolina at chapel hillHims hers healthAmerican telemedicine associationPew researchWalmart healthNorth carolinaEndpoints news

HHS panel to vote in Nov on DMD screening for newborns (NASDAQ:SRPT)

HHS panel to vote in Nov on DMD screening for newborns (NASDAQ:SRPT)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Screening panelUs department of healthAdvisory committee on heritable disorders in newbornsWave life sciencesVertex pharmaceuticalsHuman servicesMuscular dystrophy associationAdvisory committeeHeritable disordersUniform screening panelEndpoints newsParent project muscular dystrophyEdgewise therapeuticsDyne therapeuticsSolid biosciences

CMS Says It Will Spend $3 5 Billion On Leqembi, But This Is Unlikely

Skepticism may be warranted when Medicare says it expects to spend $3.5 billion on the Alzheimer’s disease drug Leqembi.

United statesEli lillyMedpage todayreportsXavier becerraClinical trials on alzheimer disease congressMedicaid service office of the actuaryDepartment of healthJournal of the american medical associationCenters for medicareHuman servicesLeqembi may beMedicaid service officeAmerican medical associationEndpoints newsHuman services secretary xavier becerraClinical trials

CVS s Shift On Humira Biosimilars May Not Be What The Doctor Ordered

CVS Caremark changed its formulary to favor Hyrimoz. But this may not be what policymakers had in mind ten years ago when they first thought about biosimilar competition.

Mark cuban cost plus drug companyQuallent pharmaceuticalsEndpoints newsFormulary watchsaysExpress scriptsMark cubanCost plus drug companyCvs caremarkCvs healthVertical integration